Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Evans

Showing results (61-70 of 208) with videos related to

Pageof 21
Sort By:
The Journal of Urology|January 25, 2003
Does retroperitoneal lymphadenectomy for testicular germ cell tumor require a different approach in the presence of horseshoe kidney?Christopher P Evans, Hari S G R Tunuguntla, Amir R Saffarian, et al.
Nutrition and Cancer|April 30, 2008
The interaction of genetic polymorphisms with lifestyle factors: implications for the dietary prevention of prostate cancerEric C Nelson, Raymond L Rodriguez, Kevin Dawson, et al.
Molecular Cancer Therapeutics|June 10, 2015
NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate CancerNagalakshmi Nadiminty, Ramakumar Tummala, Chengfei Liu, et al.
The Prostate|May 14, 2015
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibitionChengfei Liu, Wei Lou, Cameron Armstrong, et al.
The Prostate|December 6, 2013
Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cellsChengfei Liu, Yezi Zhu, Wei Lou, et al.
Clinical Genitourinary Cancer|August 10, 2017
Utility of Anterior Zone Biopsy in Men Enrolled in Active Surveillance for Prostate CancerAllison S Glass, Neil B Pugashetti, Marc A Dall'Era, et al.
Nature Clinical Practice. Urology|February 9, 2007
Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivationEric C Nelson, Angelo J Cambio, Joy C Yang, et al.
European Urology|October 13, 2014
Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular levelTheodoros Karantanos, Christopher P Evans, Bertrand Tombal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2020
Framing Pragmatic Strategies to Reduce Mortality From Bladder Cancer: An Endorsement From the Society of Urologic OncologyRalph de Vere White, Primo N Lara, Peter C Black, et al.
Urology|June 19, 2007
Cost-benefit and outcome analysis: effect of prostate biopsy undergradingAngelo J Cambio, Lars M Ellison, Karim Chamie, et al.
Pageof 21

Showing results (61-70 of 208) with videos related to

Sort By:
Pageof 21
The Journal of Urology|January 25, 2003
Does retroperitoneal lymphadenectomy for testicular germ cell tumor require a different approach in the presence of horseshoe kidney?Christopher P Evans, Hari S G R Tunuguntla, Amir R Saffarian, et al.
Nutrition and Cancer|April 30, 2008
The interaction of genetic polymorphisms with lifestyle factors: implications for the dietary prevention of prostate cancerEric C Nelson, Raymond L Rodriguez, Kevin Dawson, et al.
Molecular Cancer Therapeutics|June 10, 2015
NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate CancerNagalakshmi Nadiminty, Ramakumar Tummala, Chengfei Liu, et al.
The Prostate|May 14, 2015
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibitionChengfei Liu, Wei Lou, Cameron Armstrong, et al.
The Prostate|December 6, 2013
Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cellsChengfei Liu, Yezi Zhu, Wei Lou, et al.
Clinical Genitourinary Cancer|August 10, 2017
Utility of Anterior Zone Biopsy in Men Enrolled in Active Surveillance for Prostate CancerAllison S Glass, Neil B Pugashetti, Marc A Dall'Era, et al.
Nature Clinical Practice. Urology|February 9, 2007
Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivationEric C Nelson, Angelo J Cambio, Joy C Yang, et al.
European Urology|October 13, 2014
Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular levelTheodoros Karantanos, Christopher P Evans, Bertrand Tombal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2020
Framing Pragmatic Strategies to Reduce Mortality From Bladder Cancer: An Endorsement From the Society of Urologic OncologyRalph de Vere White, Primo N Lara, Peter C Black, et al.
Urology|June 19, 2007
Cost-benefit and outcome analysis: effect of prostate biopsy undergradingAngelo J Cambio, Lars M Ellison, Karim Chamie, et al.
Pageof 21